Judge Sets Challenging Precedents for Ozempic Lawsuits Regarding Side Effects
A recent court order presents significant challenges for individuals seeking to sue the manufacturers of Ozempic, a popular diabetes medication, over alleged adverse side effects. The ruling, issued in San Francisco, complicates the process for plaintiffs to bring their cases against the pharmaceutical giant, Novo Nordisk. The court’s determination focused on procedural aspects that could limit the breadth of claims that plaintiffs can consolidate into a single class-action lawsuit. This decision inherently stresses the necessity for plaintiffs to possibly pursue their grievances individually, a route that could diminish their negotiating power and increase legal expenses. … Read more